News On SQI Diagnostics Inc. (SQD.V) Now Under SQD.H.V
News On SQI Diagnostics Inc. (SQD.V) Now Under SQD.H.V
Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc., Debt Forgiveness, Voting Trust Agreement and Related Transactions
NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES CALGARY, Alberta, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Mr. Clive J. Beddoe ("Mr. Beddoe") announces that he has resigned as director of
SQI Diagnostics Announces Receipt of Intention to Enforce Security From Pivot Financial and Anticipated Voluntary Bankruptcy Filing
TORONTO, June 16, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF) today announced that the Company's board of directors (the "Board") has received a notice
SQI Diagnostics Reports Internal Restructuring
TORONTO, June 6, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision
SQI Diagnostics GAAP EPS of -$0.01, Revenue of $0.3M
SQI Diagnostics Reports Second Quarter 2023 Results
TORONTO, May 30, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision
SQI to Focus on Development of Point of Care Products In Respiratory Health
TORONTO, March 28, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health, today announced that it is moving to strategically focus on
SQI Diagnostics Majority Shareholders Plan Stock Sale, Exercise Warrants to Fund Company
SQI DIAGNOSTICS ANNOUNCES PROPOSED INSIDER SALES AND WARRANT EXERCISES TO FUND COMPANY
TORONTO, March 24, 2023 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and
SQI Diagnostics Announces New Capital Markets Consulting Agreement
TORONTO, March 13, 2023 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and
SQI Diagnostics Granted Another $500K Credit Facility From Pivot
Four Diagnostic Products in the Pipeline at SQI
TORONTO, March 3, 2023 /PRNewswire/ - SQI Diagnostics Inc. (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests, today announced
SQI Diagnostics Reports First Quarter 2023 Results
TORONTO, March 1, 2023 /PRNewswire/ - SQI Diagnostics Inc. (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported
SQI Diagnostics GAAP EPS of -$0.02, Revenue of $1.2M
SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results
Revenue Up 800% Year-over-Year TORONTO, Jan. 30, 2023 /PRNewswire/ - SQI Diagnostics Inc. (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision
SQI Installs Two RALI-DX Systems in Toronto Hospitals to Fight the Growing Respiratory Health Crisis in Emergency Departments
TORONTO, Jan. 18, 2023 /PRNewswire/ - SQI Diagnostics Inc. (TSXV:SQD) (OTCQB:SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests, today announced
SQI Diagnostics Inc. Closes Second Tranche of Private Placement
ACQUISITION OF SECURITIES OF SQI DIAGNOSTICS INC.
SQI Diagnostics Inc. Closes First Tranche of Private Placement With Insider Participation
SQI Diagnostics Inc. Announces Private Placement of $1.0 Million
No Data